LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $9,804,000 | +20.9% | 96,484 | +21.5% | 0.01% | +10.0% |
Q3 2016 | $8,106,000 | -14.5% | 79,422 | -0.1% | 0.01% | -16.7% |
Q2 2016 | $9,484,000 | +28.4% | 79,516 | +15.3% | 0.01% | +20.0% |
Q1 2016 | $7,385,000 | +1.7% | 68,963 | +3.0% | 0.01% | +11.1% |
Q4 2015 | $7,260,000 | +27.3% | 66,966 | +0.6% | 0.01% | +12.5% |
Q3 2015 | $5,702,000 | -16.2% | 66,574 | -1.3% | 0.01% | 0.0% |
Q2 2015 | $6,804,000 | +36.8% | 67,434 | +4.6% | 0.01% | +14.3% |
Q1 2015 | $4,973,000 | +47.3% | 64,493 | +1.7% | 0.01% | +75.0% |
Q4 2014 | $3,375,000 | +6.6% | 63,421 | -5.9% | 0.00% | 0.0% |
Q3 2014 | $3,167,000 | -25.3% | 67,390 | -1.0% | 0.00% | -33.3% |
Q2 2014 | $4,240,000 | +4.1% | 68,066 | +12.4% | 0.01% | 0.0% |
Q1 2014 | $4,073,000 | +28.9% | 60,551 | +0.8% | 0.01% | +20.0% |
Q4 2013 | $3,161,000 | +45.6% | 60,093 | +19.8% | 0.01% | +25.0% |
Q3 2013 | $2,171,000 | +22.4% | 50,171 | +5.8% | 0.00% | +33.3% |
Q2 2013 | $1,773,000 | – | 47,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |